INDIANAPOLIS, Aug. 22, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley 22nd Annual Global Healthcare Conference on Sept. 5, 2024. Jacob Van Naarden, executive vice president and president, Lilly Oncology, will participate in a fireside chat at 7:45 a.m. Eastern time.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at . A replay of the presentation will be available on this same website for approximately 90 days.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram and LinkedIn. F-LLY
Refer to: Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media)
Joe Fletcher; jfletcher@lilly.com; 317-296-2884 (Investors)
View original content to download multimedia:
SOURCE Eli Lilly and Company
印第安纳波利斯,2024年8月22日 /PRNewswire/ — 礼来公司(纽约证券交易所代码:LLY)将于2024年9月5日出席摩根士丹利第22届年度全球医疗保健会议。礼来肿瘤执行副总裁兼总裁雅各布·范纳尔登将在美国东部时间上午7点45分参加炉边谈话。
礼来投资者网站的 “网络直播和演示” 部分将提供网络直播视频,网址为。该演示文稿的重播将在同一网站上播放,为期约90天。
关于礼来
礼来是一家将科学转化为疗法的制药公司,旨在改善世界各地人们的生活。近150年来,我们一直在开创改变生活的发现,如今,我们的药物为全球超过5100万人提供了帮助。利用生物技术、化学和基因医学的力量,我们的科学家正在紧急推进新发现,以解决世界上一些最重大的健康挑战:重新定义糖尿病护理;治疗肥胖并减少其最具破坏性的长期影响;推进对抗阿尔茨海默氏病的斗争;为一些最令人衰弱的免疫系统疾病提供解决方案;以及将最难治疗的癌症转化为可控的疾病。每迈向一个更健康的世界,我们的动机都是一件事:让数百万人生活更美好。这包括提供反映我们世界多样性的创新临床试验,并努力确保我们的药物易于获得且负担得起。要了解更多信息,请访问 Lilly.com 和 lilly.com/News,或者关注我们 Facebook, Instagram 和 领英。F-LLY
请参阅:乔丹·毕晓普;jordan.bishop@lilly.com;317-473-5712(媒体)
Joe Fletcher;jfletcher@lilly.com;317-296-2884(投资者)
查看原创内容以下载多媒体:
来源 Eli Lilly and Comp